Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients

2.50
Hdl Handle:
http://hdl.handle.net/10755/151300
Type:
Presentation
Title:
Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients
Abstract:
Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Lin, Chia-Chin, PhD
P.I. Institution Name:Taipei Medical University
Title:Professor
[Research Presentation] The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach's alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores #50 or >50, respectively) and between inpatients and outpatients. The MDASI's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and 1 week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients. Key Words Taiwan, symptoms, assessment tool, validation, reliability, validity, sensitivity
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleTaiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patientsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/151300-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Lin, Chia-Chin, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Taipei Medical University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">clin@tmu.edu.tw</td></tr><tr><td colspan="2" class="item-abstract">[Research Presentation] The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach's alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores #50 or &gt;50, respectively) and between inpatients and outpatients. The MDASI's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and 1 week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients. Key Words Taiwan, symptoms, assessment tool, validation, reliability, validity, sensitivity</td></tr></table>en_GB
dc.date.available2011-10-26T10:57:59Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T10:57:59Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.